Are we looking at the next big move in FibroGen Inc (FGEN)?

FibroGen Inc (NASDAQ: FGEN) is 208.02% higher on its value in year-to-date trading and has touched a low of $0.33 and a high of $24.80 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The FGEN stock was last observed hovering at around $2.38 in the last trading session, with the day’s gains setting it 0.35%.

Currently trading at $2.73, the stock is 98.71% and 182.62% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.63 million and changing 14.71% at the moment leaves the stock -39.67% off its SMA200. FGEN registered -88.85% loss for a year compared to 6-month loss of 89.58%. The firm has a 50-day simple moving average (SMA 50) of $1.76 and a 200-day simple moving average (SMA200) of -$0.75.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a 223.12% gain in the last 1 month and extending the period to 3 months gives it a 473.53%, and is 46.77% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.04% over the week and 23.75% over the month.

Profit margin for the company is -189.81%. Distance from 52-week low is 719.08% and -88.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-19957.60%).

FibroGen Inc quarterly earnings per share for the current quarter are estimated at -$0.42 with sales reaching $38.9M over the same period.The EPS is expected to grow by 16.35% this year, but quarterly earnings will post 16.80% year-over-year. Quarterly sales are estimated to grow 13.20% in year-over-year returns.

FibroGen Inc (FGEN) Top Institutional Holders

135 institutions hold shares in FibroGen Inc (FGEN), with institutional investors hold 74.74% of the company’s shares. The shares outstanding are 94.17M, and float is at 91.65M with Short Float at 14.73%. Institutions hold 70.10% of the Float.

The top institutional shareholder in the company is Primecap Management Company with over 13.68 million shares valued at $36.93 million. The investor’s holdings represent 13.93% of the FGEN Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 9.74 million shares valued at $26.3 million to account for 9.92% of the shares outstanding. The other top investors are Blackrock Inc. which holds 8.98 million shares representing 9.15% and valued at over $24.25 million, while State Street Corporation holds 5.11% of the shares totaling 5.01 million with a market value of $13.54 million.

FibroGen Inc (FGEN) Insider Activity

A total of 12 insider transactions have happened at FibroGen Inc (FGEN) in the last six months, with sales accounting for 10 and purchases happening 2 times. The most recent transaction is an insider sale by Henderson Jeffrey William ,the company’sDirector. SEC filings show that Henderson Jeffrey William sold 2,000 shares of the company’s common stock on Sep 01 at a price of $1.03 per share for a total of $2060.0. Following the sale, the insider now owns 28866.0 shares.

FibroGen Inc disclosed in a document filed with the SEC on Aug 04 that Henderson Jeffrey William (Director) sold a total of 2,000 shares of the company’s common stock. The trade occurred on Aug 04 and was made at $1.91 per share for $3820.0. Following the transaction, the insider now directly holds 30866.0 shares of the FGEN stock.

Still, SEC filings show that on Jul 11, Henderson Jeffrey William (Director) disposed off 2,000 shares at an average price of $2.69 for $5380.0. The insider now directly holds 32,866 shares of FibroGen Inc (FGEN).

FibroGen Inc (FGEN): Who are the competitors?

The company’s main competitors (and peers) include Harvard Bioscience Inc. (HBIO) that is trading 50.64% up over the past 12 months. Illumina Inc. (ILMN) that is -36.17% lower over the same period.